Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Nectar Lifesciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nectar Lifesciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nektar Therapeutics Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nektar Therapeutics Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neogenomics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neogenomics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NeoPharm, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NeoPharm, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Caladrius Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caladrius Biosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neovacs S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neovacs S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neuland Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuland Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neuralstem Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuralstem Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neuren Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuren Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neuro Bioscience Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuro Bioscience Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neuro-Hitech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuro-Hitech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neurobiological Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurobiological Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neurocrine Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurocrine Biosciences Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OncoSil Medical Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoSil Medical Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neurogenesis Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurogenesis Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NeurogesX, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NeurogesX, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neurokine Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurokine Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neurologix Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurologix Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neuron BPh Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuron BPh Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neurosearch A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurosearch A/S Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NeuroVive Pharmaceutical AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NeuroVive Pharmaceutical AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Newron Pharmaceuticals S.p.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Newron Pharmaceuticals S.p.A. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NGL Fine-Chem Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NGL Fine-Chem Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nichi-Iko Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nichi-Iko Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nicox SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nicox SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nile Pharmaceuticals & Chemical Industries Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nile Pharmaceuticals & Chemical Industries Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nile Therapeutics, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nile Therapeutics, Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nippon Chemiphar Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nippon Chemiphar Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nippon Shinyaku Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nippon Shinyaku Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NorDiag ASA. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NorDiag ASA. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nordion Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nordion Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

North China Pharmaceutical Company Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

North China Pharmaceutical Company Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Northeast Pharmaceutical Group Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Northeast Pharmaceutical Group Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Northeast Tiger Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Northeast Tiger Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Northwest Biotherapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Northwest Biotherapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nova BioGenetics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nova BioGenetics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NovaBay Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NovaBay Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Novadel Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novadel Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NovaDx Ventures Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NovaDx Ventures Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Novagali Pharma S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novagali Pharma S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Novartis AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novartis AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Novartis India Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novartis India Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Novavax, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novavax, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cellectar Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellectar Biosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

November AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

November AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Novo Nordisk A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novo Nordisk A/S Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Novogen Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novogen Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NPS Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NPS Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NuPathe, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NuPathe, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NuRx Pharmaceuticals, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NuRx Pharmaceuticals, Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1